Patients will be the losers as Pelosi’s plan to control drug prices nearly strikes out. (STAT)

More reads

• The Democrats shepherding Pelosi’s drug pricing bill have taken plenty of campaign cash from pharma. (STAT)
• Notorious KRAS: Taking down cancer researchers’ biggest foe. (Chemical & Engineering News)
• FierceBiotech's 2019 Fierce 15. (FierceBiotech)
• Patients will be the losers as Pelosi’s plan to control drug prices nearly strikes out. (STAT)